ALC · Alcon AG
Price
Snapshot
50 fields · last close| Market Cap | $28.98B |
| P/E | 44.75 |
| Float | 486.5M |
| Beta | 1.12 |
| Volatility | 28.0% |
| Exchange | SIX |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 78 |
| Price | 70.50 |
| Change | +0.00% |
| Prev Close | 70.50 |
| Open | 70.89 |
| Day Low | 70.48 |
| Day High | 71.14 |
| Avg Vol | 1 |
| Avg $ Vol | $67.00M |
| 52W High | 87.18 |
| 52W Low | 47.80 |
| 52W Pos | 57.6% |
| From High | −19.13% |
| From Low | +47.49% |
| Max DD 1Y | −28.86% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −3.41% |
| SMA 50 | +0.19% |
| SMA 200 | −5.32% |
| RSI (14) | 43.4 |
| Vol 30D | 23.8% |
| Vol 90D | 34.7% |
| 1Y Range | 48–87 |
| Daily bars | 886 |
| Perf Week | −2.10% |
| Perf Month | +1.38% |
| Perf Quarter | +5.52% |
| Perf Half Y | −13.32% |
| Perf Year | −10.66% |
| Perf YTD | −9.15% |
| Prev Day | +0.00% |
| Clavix | B+ |
| Debt / Eq | 0.24 |
| Curr Ratio | 2.12 |
| Int Cover | 3.1× |
| FCF Margin | 13.8% |
| Rev Growth | +8.7% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 18 / 47 |
Clavix risk grade
regraded every trading dayALC grades B+, 78 of 100. Steadiest on Macro Resilience (67), most exposed on Price Stability (61, mixed). 1 of the 4 weighted dimensions sit above the Health Care median. Ranks 18 of 47 in Health Care by Clavix score.
How rough the ride is
| ALC | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.12 | 0.81 |
| Volatilityannualized | 28.0% | 20.4% |
| Max drawdown, past yearworst peak-to-trough fall | −28.9% | — |
| Typical daily movemedian absolute daily change | 0.93% | — |
| Days beyond ±3%of the last 252 sessions | 187% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| ALC | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.12 | 0.81 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| ALC | |
|---|---|
| 1 week | −2.1% |
| 1 month | +1.4% |
| Year to date | −9.1% |
| 1 year | −10.7% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| ALC | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 18since 8 Jul |
| Average score0 most bearish, 100 most bullish | 68 |
| Bullish · bearisharticles above 60 · below 40 | 14 · 0 |
| Directionarticles whose tone is improving vs worsening | 14 ↑ 0 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| ALC | |
|---|---|
| Revenue growthyear over year | +8.7% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Health Care
47 companies| Metric | ALC | Sector spread | Median |
|---|---|---|---|
| Beta | 1.12 | 0.81 | |
| Volatility | 28.0% | 20.4% | |
| P/E | 44.75 | 26.82 | |
| Debt / equity | 0.24 | 0.71 | |
| Current ratio | 2.12 | 1.58 | |
| FCF margin | 13.8% | 8.7% | |
| Interest coverage | 3.1× | 6.3× |
Recent news
most recent scored articles · the chip is the article’s score · click to openThe article weighs whether Alcon (ALC) stock is worth keeping, citing its acquisitions, partnerships, and new product launches as growth supports, while flagging tariffs and heavy competition as key risks.
An analyst-style piece argues Alcon (ALC) is positioned for a valuation re-rating, noting its equipment-to-consumables business model with recurring revenue. At $72, the stock trades at roughly 18 times forward earnings, and management has raised core EPS growth guidance to 12-15% while targeting a 25% core operating margin by FY2027 alongside ongoing capital returns.
Alcon reported strong core operating profit in the quarter, up 17% excluding a one-time non-cash $402 million charge, and raised its full-year 2026 profit forecast for the second consecutive quarter.
Swiss-American eye care company Alcon raised its full-year profit guidance and reduced its estimated tariff impact to $40 million to $90 million, factoring in an anticipated $60 million refund from the U.S. government.
The article text provided consists only of a press release headline stating that Alcon's second-quarter 2026 growth was driven by new product launches and strong commercial execution; no body content or details were supplied.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| GEHC | GE Healthcare Technologies Inc | B- | $31.10B | 15.86 | 0.82 | Compare |
| LH | Labcorp Holdings Inc | A- | $26.51B | 26.82 | 0.88 | Compare |
| DGX | Quest Diagnostics Inc | A- | $26.17B | 24.97 | 0.56 | Compare |
| RMD | Resmed Inc | B+ | $32.94B | 21.74 | 0.77 | Compare |
| CNC | Centene Corp | B | $33.12B | — | 1.08 | Compare |
| DXCM | Dexcom Inc | B | $33.17B | 33.86 | 1.45 | Compare |
| VEEV | Veeva Systems Inc | B- | $34.18B | 45.52 | 0.91 | Compare |
| STE | STERIS plc | A- | $21.90B | 27.69 | 0.88 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.